The Integrator Complex Recognizes a New Double Mark on the RNA Polymerase II Carboxyl-terminal Domain

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2010 May 12

PMID 20457598

Citations 60

Authors

Sylvain Egloff

Sylwia Anna Szczepaniak

Martin Dienstbier

Alice Taylor

Sophie Knight

Shona Murphy

Affiliations

Soon will be listed here.

Abstract

The carboxyl-terminal domain (CTD) of the largest subunit of RNA polymerase II (pol II) comprises multiple tandem repeats of the heptapeptide Tyr(1)-Ser(2)-Pro(3)-Thr(4)-Ser(5)-Pro(6)-Ser(7). This unusual structure serves as a platform for the binding of factors required for expression of pol II-transcribed genes, including the small nuclear RNA (snRNA) gene-specific Integrator complex. The pol II CTD specifically mediates recruitment of Integrator to the promoter of snRNA genes to activate transcription and direct 3' end processing of the transcripts. Phosphorylation of the CTD and a serine in position 7 are necessary for Integrator recruitment. Here, we have further investigated the requirement of the serines in the CTD heptapeptide and their phosphorylation for Integrator binding. We show that both Ser(2) and Ser(7) of the CTD are required and that phosphorylation of these residues is necessary and sufficient for efficient binding. Using synthetic phosphopeptides, we have determined the pattern of the minimal Ser(2)/Ser(7) double phosphorylation mark required for Integrator to interact with the CTD. This novel double phosphorylation mark is a new addition to the functional repertoire of the CTD code and may be a specific signal for snRNA gene expression.

Citing Articles

Post-transcriptional monoadenylation by TENT2 terminates human RNA polymerase III transcript 3' end processing and promotes 7SL RNA biogenesis.

Ocheltree C, Skrable B, Pimentel A, Nicholson-Shaw T, Lee S, Lykke-Andersen J bioRxiv. 2025; .

PMID: 39975393 PMC: 11838476. DOI: 10.1101/2025.01.31.635978.

Herpes simplex virus 1 inhibits phosphorylation of RNA polymerase II CTD serine-7.

Whisnant A, Dyck Dionisi O, Salazar Sanchez V, Rappold J, Djakovic L, Grothey A J Virol. 2024; 98(10):e0117824.

PMID: 39316591 PMC: 11494995. DOI: 10.1128/jvi.01178-24.

IntS6 and the Integrator phosphatase module tune the efficiency of select premature transcription termination events.

Fujiwara R, Zhai S, Liang D, Shah A, Tracey M, Ma X Mol Cell. 2023; 83(24):4445-4460.e7.

PMID: 37995689 PMC: 10841813. DOI: 10.1016/j.molcel.2023.10.035.

Never a dull enzyme, RNA polymerase II.

Huang J, Ji X Transcription. 2023; 14(1-2):49-67.

PMID: 37132022 PMC: 10353340. DOI: 10.1080/21541264.2023.2208023.

Mutations in the non-coding RNU4ATAC gene affect the homeostasis and function of the Integrator complex.

Almentina Ramos Shidi F, Cologne A, Delous M, Besson A, Putoux A, Leutenegger A Nucleic Acids Res. 2022; 51(2):712-727.

PMID: 36537210 PMC: 9881141. DOI: 10.1093/nar/gkac1182.

References

Stiller J, Cook M . Functional unit of the RNA polymerase II C-terminal domain lies within heptapeptide pairs. Eukaryot Cell. 2004; 3(3):735-40. PMC: 420137. DOI: 10.1128/EC.3.3.735-740.2004. View

Egloff S, OReilly D, Murphy S . Expression of human snRNA genes from beginning to end. Biochem Soc Trans. 2008; 36(Pt 4):590-4. DOI: 10.1042/BST0360590. View

Dignam J, Lebovitz R, Roeder R . Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983; 11(5):1475-89. PMC: 325809. DOI: 10.1093/nar/11.5.1475. View

Hernandez N . Formation of the 3' end of U1 snRNA is directed by a conserved sequence located downstream of the coding region. EMBO J. 1985; 4(7):1827-37. PMC: 554424. DOI: 10.1002/j.1460-2075.1985.tb03857.x. View

Corden J . Transcription. Seven ups the code. Science. 2007; 318(5857):1735-6. DOI: 10.1126/science.1152624. View

Egloff S, OReilly D, Chapman R, Taylor A, Tanzhaus K, Pitts L . Serine-7 of the RNA polymerase II CTD is specifically required for snRNA gene expression. Science. 2007; 318(5857):1777-9. PMC: 2263945. DOI: 10.1126/science.1145989. View

Izzard R, Jackson S, Smith G . Competitive and noncompetitive inhibition of the DNA-dependent protein kinase. Cancer Res. 1999; 59(11):2581-6. View

McCracken S, Fong N, Yankulov K, Ballantyne S, Pan G, GREENBLATT J . The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature. 1997; 385(6614):357-61. DOI: 10.1038/385357a0. View

Dominski Z, Yang X, Purdy M, Wagner E, Marzluff W . A CPSF-73 homologue is required for cell cycle progression but not cell growth and interacts with a protein having features of CPSF-100. Mol Cell Biol. 2005; 25(4):1489-500. PMC: 548002. DOI: 10.1128/MCB.25.4.1489-1500.2005. View

10.

Buratowski S . The CTD code. Nat Struct Biol. 2003; 10(9):679-80. DOI: 10.1038/nsb0903-679. View

11.

Medlin J, Scurry A, Taylor A, Zhang F, Peterlin B, Murphy S . P-TEFb is not an essential elongation factor for the intronless human U2 snRNA and histone H2b genes. EMBO J. 2005; 24(23):4154-65. PMC: 1356315. DOI: 10.1038/sj.emboj.7600876. View

12.

Medlin J, Uguen P, Taylor A, Bentley D, Murphy S . The C-terminal domain of pol II and a DRB-sensitive kinase are required for 3' processing of U2 snRNA. EMBO J. 2003; 22(4):925-34. PMC: 145437. DOI: 10.1093/emboj/cdg077. View

13.

Dvir A, Peterson S, Knuth M, Lu H, Dynan W . Ku autoantigen is the regulatory component of a template-associated protein kinase that phosphorylates RNA polymerase II. Proc Natl Acad Sci U S A. 1992; 89(24):11920-4. PMC: 50669. DOI: 10.1073/pnas.89.24.11920. View

14.

Jacobs E, Ogiwara I, Weiner A . Role of the C-terminal domain of RNA polymerase II in U2 snRNA transcription and 3' processing. Mol Cell Biol. 2004; 24(2):846-55. PMC: 343789. DOI: 10.1128/MCB.24.2.846-855.2004. View

15.

Phatnani H, Greenleaf A . Phosphorylation and functions of the RNA polymerase II CTD. Genes Dev. 2006; 20(21):2922-36. DOI: 10.1101/gad.1477006. View

16.

Lees-Miller S, Chen Y, Anderson C . Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen. Mol Cell Biol. 1990; 10(12):6472-81. PMC: 362924. DOI: 10.1128/mcb.10.12.6472-6481.1990. View

17.

Egloff S, Murphy S . Role of the C-terminal domain of RNA polymerase II in expression of small nuclear RNA genes. Biochem Soc Trans. 2008; 36(Pt 3):537-9. DOI: 10.1042/BST0360537. View

18.

Hernandez N . Small nuclear RNA genes: a model system to study fundamental mechanisms of transcription. J Biol Chem. 2001; 276(29):26733-6. DOI: 10.1074/jbc.R100032200. View

19.

Chapman R, Heidemann M, Hintermair C, Eick D . Molecular evolution of the RNA polymerase II CTD. Trends Genet. 2008; 24(6):289-96. DOI: 10.1016/j.tig.2008.03.010. View

20.

Chapman R, Heidemann M, Albert T, Mailhammer R, Flatley A, Meisterernst M . Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7. Science. 2007; 318(5857):1780-2. DOI: 10.1126/science.1145977. View